SEC Form 4 · accession 0001209191-16-105308
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M. Andrew Wade
Officer — SVP and CFO
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2016 | F | 3,988 | $16.30 | D | 92,215 | D | |
| Common StockF2 | Mar 1, 2016 | A | 50,000 | $0.00 | A | 142,215 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award.
- F2The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant.